Innoviz Technologies (INVZ) grants COO RSUs and options

Rhea-AI Filing Summary

Innoviz Technologies reported that Chief Operating Officer Ido Luski received new equity awards on August 4, 2026. He was granted 64,688 Restricted Share Units and share options for 69,296 ordinary shares at a 0.4200 per-share exercise price, both vesting one-fourth on August 4, 2027 and quarterly thereafter through 2030, subject to continued service. Following these awards, he directly owns 393,701 ordinary shares, including shares underlying RSUs.

Insider Trade Summary

Net Buyer: 64,688 shares

Net Buy 2 txns

Insider Luski Ido

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Share Option F4	69,296	$0.00	$0.00
Grant/Award	Ordinary Shares F1, F2, F3	64,688	$0.00	$0.00

Holdings After Transaction: Share Option — 69,296 shares (Direct); Ordinary Shares — 393,701 shares (Direct)

Footnotes (4)

1. F1. Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
2. F2. Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
3. F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
4. F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Key Figures

RSUs granted: 64,688 shares Stock options granted: 69,296 shares Exercise price: 0.4200 per share +2 more

5 metrics

RSUs granted 64,688 shares Restricted Share Units granted to COO on August 4, 2026

Stock options granted 69,296 shares Share options granted on August 4, 2026

Exercise price 0.4200 per share Conversion or exercise price for newly granted options

Shares owned after awards 393,701 shares Ordinary shares directly owned following August 4, 2026 awards

RSU-linked shares outstanding 230,260 shares Ordinary shares issuable upon vesting of RSUs held by COO

Key Terms

Restricted Share Units (RSUs), ordinary share, exercise price, vesting

4 terms

Restricted Share Units (RSUs) financial

"Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

ordinary share financial

"Each RSU represents a contingent right to receive one ordinary share"

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

exercise price financial

"No exercise price is applicable"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 04:21 PM Accepted by SEC EDGAR 08/05/2026 - 04:21 PM Learn about SEC filing dates

FAQ

What equity awards did Innoviz Technologies (INVZ) grant to COO Ido Luski?

Innoviz Technologies granted COO Ido Luski 64,688 Restricted Share Units and 69,296 share options on August 4, 2026. The options carry a 0.4200 per-share exercise price and both awards vest from 2027 through 2030.

How many Innoviz Technologies (INVZ) shares does COO Ido Luski hold after these grants?

After these awards, Ido Luski directly holds 393,701 ordinary shares of Innoviz Technologies. This figure includes 230,260 shares underlying RSU grants that will be issued only upon future vesting.

What are the vesting terms of the new RSUs granted to Innoviz (INVZ) COO?

The new 64,688 RSUs granted to the Innoviz COO vest one-fourth on August 4, 2027. The remaining RSUs vest quarterly through 2030, and each RSU converts into one ordinary share, with no exercise price.

What are the vesting and expiration terms of Ido Luski’s new Innoviz (INVZ) stock options?

The 69,296 share options granted on August 4, 2026 vest one-fourth on August 4, 2027. The remaining options vest quarterly through 2030, have a 0.4200 per-share exercise price, and expire on August 4, 2033.

How many RSU-linked shares does Innoviz Technologies (INVZ) COO have in total?

Innoviz reports that COO Ido Luski has 230,260 ordinary shares issuable upon vesting of RSUs. These reflect multiple grants from 2022 to 2026, with vesting schedules running quarterly through 2029 and one grant vesting through 2030.

What conditions apply to the vesting of Innoviz (INVZ) COO’s RSUs and options?

All RSU and option awards for the Innoviz COO are subject to a continued service condition. Vesting occurs only if he remains a service provider to Innoviz on each specified vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luski Ido

(Last) (First) (Middle)

C/O INNOVIZ TECHNOLOGIES LTD.

5 URI ARIAV STREET, BUILDING C

(Street)

ROSH HA'AIN 4809202

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innoviz Technologies Ltd. [ INVZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/04/2026		A		64,688(1)	A	$0.00	393,701(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$0.42	08/04/2026		A		69,296		(4)	08/04/2033	Ordinary Shares	69,296	$0.00	69,296	D

Explanation of Responses:

1. Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

2. Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

	/s/ Dafna Raz - Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)